-
Time to and Time in Better Health States With Sotatercept for Pulmonary Arterial Hypertension: A Modeling Study
Sep 9, 2025, 16:22 PM -
Burden of Healthcare Waste for European Hospitals: Findings From an AI-Based Literature Research
Sep 9, 2025, 16:22 PM -
Characterizing Comorbidities and Co-Occurring Conditions in Adults with Generalized Anxiety Disorder in the United States
Sep 9, 2025, 16:22 PM -
Feasibility of Building a Generic Partitioned Survival Model for Oncology: Essential Components and Technical Implementation
Sep 9, 2025, 16:22 PM -
Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets
Sep 9, 2025, 16:22 PM -
Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Prediction of Query Outcomes in the Setting of Observational Studies
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting
Sep 9, 2025, 16:22 PM -
Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries
Sep 9, 2025, 16:22 PM -
An Economic Evaluation of Risankizumab vs. Adalimumab in Moderate to Severe Plaque Psoriasis Adult Patients in Egypt
Sep 9, 2025, 16:22 PM -
LLM Engineering in HEOR: Approaches to Improving Accuracy in Clinical Data Extraction
Sep 9, 2025, 16:22 PM -
Design Operating Characteristics in a Noninterventional Study Framework
Sep 9, 2025, 16:22 PM -
The Growing Importance of Reserve Antibiotics in Organ Transplant Care and the Role of Timely Appropriate Antibiotic Treatment to Preserve the Benefits of Prior Health Investments
Sep 9, 2025, 16:22 PM -
Pertussis Vaccination and Test Rates in Germany by Asthma-COPD Comorbidity Status: A Healthcare Claims Data Analysis in Germany
Sep 9, 2025, 16:22 PM -
The IMPACT Framework: A Value Assessment Framework for Holistic Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Immunotherapy for NSCLC Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Estimation of HER2-Negative Metastatic Breast Cancer Population Eligible for Innovative Treatments in France
Sep 9, 2025, 16:22 PM -
Characterizing the UK Population Living With Von Willebrand Disease: Foundational Data for Health Economics and Outcomes Research
Sep 9, 2025, 16:22 PM -
Costing Analysis for the Management of Localized Renal Cell Carcinoma From the UK NHS Perspective
Sep 9, 2025, 16:22 PM -
Gender Differences in the Economic Burden of Alcohol Use in Belgium
Sep 9, 2025, 16:22 PM
